IHT Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-5,464
| Closed | -$295K | – | 1152 |
|
|
2024
Q2 | $295K | Sell |
5,464
-1,344
| -20% | -$72.6K | 0.01% | 806 |
|
|
2024
Q1 | $464K | Sell |
6,808
-110
| -2% | -$7.5K | 0.02% | 663 |
|
|
2023
Q4 | $433K | Sell |
6,918
-652
| -9% | -$40.8K | 0.02% | 650 |
|
|
2023
Q3 | $344K | Sell |
7,570
-400
| -5% | -$18.2K | 0.02% | 675 |
|
|
2023
Q2 | $447K | Sell |
7,970
-211
| -3% | -$11.8K | 0.02% | 581 |
|
|
2023
Q1 | $370K | Sell |
8,181
-1,919
| -19% | -$86.8K | 0.02% | 616 |
|
|
2022
Q4 | $411K | Buy |
10,100
+55
| +0.5% | +$2.24K | 0.03% | 548 |
|
|
2022
Q3 | $656K | Buy |
10,045
+2,668
| +36% | +$174K | 0.05% | 380 |
|
|
2022
Q2 | $448K | Sell |
7,377
-8
| -0.1% | -$486 | 0.04% | 409 |
|
|
2022
Q1 | $464K | Hold |
7,385
| – | – | 0.04% | 431 |
|
|
2021
Q4 | $560K | Buy |
7,385
+835
| +13% | +$63.3K | 0.04% | 402 |
|
|
2021
Q3 | $733K | Sell |
6,550
-2,750
| -30% | -$308K | 0.06% | 318 |
|
|
2021
Q2 | $1.51M | Buy |
9,300
+700
| +8% | +$113K | 0.1% | 224 |
|
|
2021
Q1 | $1.05M | Sell |
8,600
-816
| -9% | -$99.4K | 0.08% | 259 |
|
|
2020
Q4 | $1.44M | Buy |
9,416
+1,609
| +21% | +$246K | 0.12% | 176 |
|
|
2020
Q3 | $653K | Buy |
7,807
+3,428
| +78% | +$287K | 0.07% | 275 |
|
|
2020
Q2 | $322K | Buy |
+4,379
| New | +$322K | 0.04% | 393 |
|
|
2019
Q3 | – | Sell |
-5,383
| Closed | -$254K | – | 614 |
|
|
2019
Q2 | $254K | Buy |
+5,383
| New | +$254K | 0.04% | 433 |
|
|
2018
Q4 | – | Sell |
-5,051
| Closed | -$224K | – | 481 |
|
|
2018
Q3 | $224K | Hold |
5,051
| – | – | 0.05% | 386 |
|
|
2018
Q2 | $297K | Sell |
5,051
-500
| -9% | -$29.4K | 0.08% | 305 |
|
|
2018
Q1 | $240K | Buy |
5,551
+50
| +0.9% | +$2.16K | 0.06% | 320 |
|
|
2017
Q4 | $143K | Hold |
5,501
| – | – | 0.04% | 411 |
|
|
2017
Q3 | $108K | Sell |
5,501
-126
| -2% | -$2.47K | 0.05% | 343 |
|
|
2017
Q2 | $20 | Buy |
5,627
+80
| +1% | – | 0.01% | 778 |
|
|
2017
Q1 | $110K | Buy |
+5,547
| New | +$110K | 0.07% | 264 |
|